retatrutide clinical trials safety data New Phase 3 just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Efficacy and safety of retatrutide,

Despite being a relatively new class of medication, researchers conducted a comprehensive analysis on a significant population of nearly half a million adults with type 2 diabetes over a follow-up period of 7 years, providing valuable insights into the effectiveness and safety of GLP-1RA

Sagging and laxity result when the rate of fat loss exceeds the rate of skin retraction, especially when weight loss is rapid, collagen quality is reduced, or the patient already has early laxity

When you wake up, you're in a catabolic (breakdown) state

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

We are here to support you in feeling better, looking better, and living a healthier, more fulfilling lifestyle

Cardiovascular benefits: Numerous studies have demonstrated that GLP-1s reduce cardiovascular risk in patients with diabetes or those at high cardiovascular risk, independent of their HbA1c levels